Skip to main content
ANIP
NASDAQ Life Sciences

Cortrophin Gel Guidance Slashed, ANI Pharma Tumbles 6%

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$78.46
Mkt Cap
$1.785B
52W Low
$67.98
52W High
$99.5
52W Position info
15% above low
Off High info
21% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

ANIP sits 15% above its 52-week low of $67.98.

Summary

ANI Pharmaceuticals cut its full-year revenue outlook for Cortrophin Gel, its key growth driver, to $520M-$540M from $540M-$575M. The stock fell 6% as the reduction overshadows an otherwise strong Q2: revenue of $266M beat estimates, and adjusted EPS of $2.21 topped the $2.04 consensus. The company reaffirmed total company guidance of $1.08B-$1.14B and adjusted EPS of $9.19-$9.69, but the Cortrophin cut signals headwinds in its most important product. This follows the Q2 8-K filed earlier today that highlighted Cortrophin's 43.5% revenue jump, making the guidance cut a sharp reversal. Watch for management commentary on the earnings call to clarify whether this is a temporary setback or a longer-term demand issue.

At the time of this announcement, ANIP was trading at $78.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $67.98 to $99.50. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ANIP - Latest Insights

ANIP
Nov 05, 2026, 5:13 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $69.00
Real-time Price: $67.41 info
Change: -$1.59 (-2%) info
Market Cap: $1.548B info
ANIP
Nov 05, 2026, 6:58 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $75.00
Real-time Price: $67.41 info
Change: -$7.59 (-10%) info
Market Cap: $1.548B info
ANIP
Nov 05, 2026, 6:56 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $71.72
Real-time Price: $67.41 info
Change: -$4.31 (-6%) info
Market Cap: $1.548B info
ANIP
Nov 05, 2026, 6:51 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $72.00
Real-time Price: $67.41 info
Change: -$4.59 (-6%) info
Market Cap: $1.548B info
ANIP
Nov 05, 2026, 1:33 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $72.00
Real-time Price: $67.41 info
Change: -$4.59 (-6%) info
Market Cap: $1.548B info